Testing the Developmental Origins Hypothesis
CHIPS-Child
CHIPS-Child:Testing the Developmental Origins Hypothesis
1 other identifier
observational
626
8 countries
41
Brief Summary
INTRODUCTION: CHIPS-Child is a parallel, ancillary study to the CHIPS randomized controlled trial (RCT). CHIPS is designed to determine whether 'less tight' control \[target diastolic BP (dBP) 100mmHg\] or 'tight' control \[target dBP 85mmHg\] of non-proteinuric hypertension in pregnancy is better for the baby without increasing maternal risk. CHIPS-Child is a follow up study at 12 m corrected post-gestational age (± 2 m) limited to non-invasive examination \[anthropometry, hair cortisol, buccal swabs for epigenetic testing and a maternal questionnaire about infant feeding practices and background\]. Annual contact will be maintained in years 2-5 and contact will include annual parental measurement of the child's height, weight and waist circumference. OBJECTIVE: To directly test, for the first time in humans, whether differential blood pressure (BP) control in pregnancy has developmental programming effects, independent of birthweight. We predict that, like famine or protein malnutrition, 'tight' (vs. 'less tight') control of maternal BP will be associated with fetal under-nutrition and effects will be consistent with developmental programming.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2012
Longer than P75 for all trials
41 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 24, 2012
CompletedFirst Posted
Study publicly available on registry
March 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2019
CompletedMarch 6, 2012
March 1, 2012
7 years
February 24, 2012
March 1, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
difference in 'change in z score for weight' at 12 m(+/- 2m)
Between-group difference in early postnatal weight gain ('change in z score for weight') between birth and 12 m (p\<0.05), 24m, 36m, 48m \& 60m.
birth to 12m (+/-2m) of age, 24m, 36m, 48m, 60m
Secondary Outcomes (2)
hypothalamic pituitary adrenal axis function
average of 12m (+/-2m) of age
differences in DNA methylation
average of 12 m (+/- 2m) of age
Study Arms (2)
Tight
Children born to women in the CHIPS RCT randomized to "Tight" blood pressure control \[target diastolic BP 85mmHg\]
Less Tight
Children born to women in the CHIPS RCT randomized to "Less Tight" \[target diastolic BP 100mmHg\].
Eligibility Criteria
Only women participating in the CHIPS RCT and their children born after recruitment are eligible to participate in CHIPS-Child.
You may qualify if:
- All women participating in CHIPS and their children born after recruitment.
You may not qualify if:
- Women who have experienced the loss of their pregnancy or child after recruitment into CHIPS.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (41)
Yale-New Haven Hospital
New Haven, Connecticut, 06510, United States
Norton Hospital Downtown & Suburban
Louisville, Kentucky, 40202, United States
Copper University Hospital
Camden, New Jersey, 08103, United States
Oregon Health & Science University
Portland, Oregon, 97239, United States
Ipswich Hospital
Ipswich, Australia
King Edward Memorial Hospital
Subiaco, Australia
Royal Alexandra Hospital
Edmonton, Alberta, Canada
Surrey Memorial Hospital: Jim Pttison Outpatient Care & Surgery Centre
Surrey, British Columbia, Canada
BC Children & Women's Health Centre
Vancouver, British Columbia, V6H 3N1, Canada
IWK Health Centre
Halifax, Nova Scotia, Canada
London Health Sciences Centre
London, Ontario, Canada
CHUS Fleurimont
Sherbrooke, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Hopital Sainte-Justine
Montreal, Quebec, Canada
Royal University Hospital
Saskatoon, Saskatchewan, Canada
Hospital Base Osorno
Osorno, Chile
Hospital Dr Sotero del Rio
Puente Alto, Chile
Tartu University Hospital - Women's Clinic
Tartu, Estonia
Academic Medical Center
Amsterdam, Netherlands
OLVG
Amsterdam, Netherlands
VU Medical Center
Amsterdam, Netherlands
UMCG
Groningen, Netherlands
Tergooiziekenhuizen
Hilversum, Netherlands
MUMC Maastricht
Maastricht, Netherlands
St Antonius Ziekenhuis
Nieuwegein, Netherlands
Diakonessen Ziekenhuis
Utrecht, Netherlands
UMCU
Utrecht, Netherlands
Maxima Medical Centre
Veldhoven, Netherlands
Isala Klinieken Zwolle
Zwolle, Netherlands
Christchurch Women's Hospital
Christchurch, New Zealand
Birmingham Women's Hospital
Birmingham, United Kingdom
Bradford Royal Infirmary
Bradford, United Kingdom
Royal Lancaster Infirmary
Lancaster, United Kingdom
Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
Nottingham City Hospital
Nottingham, United Kingdom
Southport & Ormskirk Hospital
Ormskirk, United Kingdom
Derriford Hospital
Plymouth, United Kingdom
City Hospitals Sunderland NHS Foundation Trust
Sunderland, United Kingdom
Singleton Hospital
Swansea, United Kingdom
New Cross Hospital
Wolverhampton, United Kingdom
York District Hospital
York, United Kingdom
Related Publications (7)
Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009 Sep;27(5):358-68. doi: 10.1055/s-0029-1237424. Epub 2009 Aug 26.
PMID: 19711246BACKGROUNDWaterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr. 2007;27:363-88. doi: 10.1146/annurev.nutr.27.061406.093705.
PMID: 17465856BACKGROUNDGilbert EF, Varakis J, Opitz JM, ZuRhein GM, Ware R, Viseskul C, Kaveggia EG, Hartmann HA. Generalized gangliosidosis type II (juvenile GM1 gangliosidosis). A pathological, histochemical and ultrastructural study. Z Kinderheilkd. 1975 Sep 11;120(3):151-80. doi: 10.1007/BF00439006.
PMID: 126533BACKGROUNDPainter RC, Roseboom TJ, Bleker OP. Prenatal exposure to the Dutch famine and disease in later life: an overview. Reprod Toxicol. 2005 Sep-Oct;20(3):345-52. doi: 10.1016/j.reprotox.2005.04.005.
PMID: 15893910BACKGROUNDTobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, Slagboom PE, Heijmans BT. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009 Nov 1;18(21):4046-53. doi: 10.1093/hmg/ddp353. Epub 2009 Aug 4.
PMID: 19656776BACKGROUNDSilveira PP, Portella AK, Goldani MZ, Barbieri MA. Developmental origins of health and disease (DOHaD). J Pediatr (Rio J). 2007 Nov-Dec;83(6):494-504. doi: 10.2223/JPED.1728.
PMID: 18074050BACKGROUNDCameron N, Demerath EW. Critical periods in human growth and their relationship to diseases of aging. Am J Phys Anthropol. 2002;Suppl 35:159-84. doi: 10.1002/ajpa.10183.
PMID: 12653312BACKGROUND
Biospecimen
1. \~150 strands of hair 2. Four buccal swabs
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura A Magee, MD
BC Children & Women's Health Centre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor of Medicine
Study Record Dates
First Submitted
February 24, 2012
First Posted
March 6, 2012
Study Start
January 1, 2012
Primary Completion
January 1, 2019
Study Completion
January 1, 2019
Last Updated
March 6, 2012
Record last verified: 2012-03